Cslbehring.de - Global Biotechnology Company | CSL
Provided by Alexa ranking,
cslbehring.de has ranked
N/A in
N/A and
9,394,839 on the world.
cslbehring.de reaches roughly
327 users per day and delivers about
9,824 users each month. The domain cslbehring.de uses a Commercial suffix and it's server(s) are located in
N/A with the IP number
12.3.33.229 and it is a
.de domain.
WEBCSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas.
List of domain same IP 12.3.33.229
Search Results related to cslbehring.de on Search Engine
-
Global Biotechnology Company | CSL
https://www.csl.com/we-are-csl/our-businesses-and-products/csl-behring
WEBCSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas.
DA: 94 PA: 53 MOZ Rank: 72
-
Global Biotechnology Company | CSL
https://www.csl.com/
WEBCSL Behring is a global biotech leader with a broad range of biotherapies for rare and serious diseases including bleeding disorders, immunodeficiencies, hereditary angioedema, neurological disorders and Alpha 1 Antitrypsin Deficiency.
DA: 78 PA: 46 MOZ Rank: 5
-
CSL Behring Products | CSL
https://www.csl.com/we-are-csl/our-businesses-and-products/csl-behring/csl-behring-products
WEBJul 7, 2023 · Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry. CSL Behring: Rare & Serious Diseases
DA: 74 PA: 70 MOZ Rank: 46
-
CSL Behring - Wikipedia
https://en.wikipedia.org/wiki/CSL_Behring
WEBCSL Behring is a biopharmaceutical company, manufacturing plasma-derived, and recombination therapeutic products. The company is a combination of Behringwerke, founded in 1904 in Marburg , Germany by Emil von Behring , and the Commonwealth Serum Laboratories (CSL), established in Australia in 1916 to provide vaccines to the …
DA: 72 PA: 55 MOZ Rank: 78
-
Our Company - CSL Behring
https://www.cslbehring.ch/en-us/our-company
WEBCSL Behring AG in Bern. Our company specializes in the manufacture of biotherapeutic products. She has over a century of experience in treating different diseases around the world. We are committed to patients suffering from blood clotting disorders, immunological diseases, enzymatic deficits and other rare diseases.
DA: 47 PA: 47 MOZ Rank: 83
-
CSL Behring Announces the First Patient Has Received FDA …
https://newsroom.csl.com/2023-06-20-CSL-Behring-Announces-the-First-Patient-Has-Received-FDA-Approved-HEMGENIX-R-etranacogene-dezaparvovec-drlb-for-Hemophilia-B
WEBKING OF PRUSSIA, Pa., June 20, 2023 / PRNewswire / -- Global biotechnology leader CSL Behring today announced that the first patient has received U.S. Food and Drug Administration (FDA) approved HEMGENIX ® (etranacogene dezaparvovec-drlb) for hemophilia B in the United States. HEMGENIX is the first and only gene therapy for the …
DA: 74 PA: 95 MOZ Rank: 69
-
Our Company - CSL Behring
https://www.cslbehring.de/en-us/our-company
WEBCSL Behring's portfolio of innovative medicines includes a wide range of recombinant and plasma-derived products for treating bleeding disorders, immune deficiencies and chronic inflammatory demyelinating polyneuropathy, as well as hereditary angioedema and Alpha 1 Antitrypsin Deficiency. Learn More. What Drives Us.
DA: 89 PA: 90 MOZ Rank: 37
-
Global Newsroom | CSL
https://newsroom.csl.com/
WEBGlobal Newsroom. Recent News Releases. Featuring releases from CSL, CSL Behring, CSL Seqirus and CSL Vifor. How Can We Help You? Media Resources. Media Contacts. CSL. Mini brains and lab-on-a-chip wearables: Jumar Bioincubator officially begins its mission to build “Australia’s next CSL”
DA: 94 PA: 32 MOZ Rank: 55
-
CSL | LinkedIn
https://www.linkedin.com/company/csl
WEBCSL is a leading global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and...
DA: 40 PA: 83 MOZ Rank: 72
-
Products - CSL Behring
https://www.cslbehring.ch/en-us/products
WEBCSL Behring Switzerland. Products. Our Products. We specialise in the manufacture of biotherapeutic products, with more than a century of experience in the treatment of various diseases worldwide. In contrast to chemically manufactured pharmaceuticals, biotherapeutic products are manufactured from human plasma or by recombinant processes.
DA: 53 PA: 50 MOZ Rank: 59
Alexa Rank
GLOBAL RANK
Alexa Reach
Page length
Alexa Rank Country N/A
Daily Unique Visitors
Monthly Unique Visitors
Vistor via Country
Country lang
Country code
Total visitor
Country
Country code
Total visitor
Alexa Traffic Graph
Alexa daily traffic trend graph
Alexa daily pageviews (percent) graph
Alexa daily pageviews per user graph
Alexa time on site (in minutes) graph
Alexa bounce rate (percent) graph
Alexa search visits graph
SEOquake Zone
| Title |
|
|
Tips |
| Description |
|
|
Tips |
| Keywords |
|
|
Tips |
| Viewport |
|
|
Tips |
| Icon |
|
|
|
| UTF-8 |
|
|
|
Mini site formation by Alexa Rank
DNS Record
| Host |
Type |
Class |
TTL |
Extra |
| cslbehring.de |
SOA |
IN |
21600 |
Mname: dbru.br.ns.els-gms.att.net
Rname: rm-hostmaster.ems.att.com
Serial: 23
Refresh: 10800
Retry: 3600
Expire: 604800
Minimum-ttl: 86400
|
| cslbehring.de |
TXT |
IN |
21600 |
Txt: 1z583zmcdrfjh27vybynfxh9qn1qy9h2
Entries_0: 1z583zmcdrfjh27vybynfxh9qn1qy9h2
|
| cslbehring.de |
A |
IN |
600 |
Ip: 12.3.33.229
|
| cslbehring.de |
NS |
IN |
21600 |
Target: dmtu.mt.ns.els-gms.att.net
|
| cslbehring.de |
NS |
IN |
21600 |
Target: dbru.br.ns.els-gms.att.net
|
Hosting and Whois Zone
| IP |
12.3.33.229 |
| Domain infomation |
% Restricted rights.
%
% Terms and Conditions of Use
%
% The above data may only be used within the scope of technical or
% administrative necessities of Internet operation or to remedy legal
% problems.
% The use for other purposes, in particular for advertising, is not permitted.
%
% The DENIC whois service on port 43 doesn't disclose any information concerning
% the domain holder, general request and abuse contact.
% This information can be obtained through use of our web-based whois service
% available at the DENIC website:
% http://www.denic.de/en/domains/whois-service/web-whois.html
%
%
Domain: cslbehring.de
Nserver: dbru.br.ns.els-gms.att.net
Nserver: dmtu.mt.ns.els-gms.att.net
Status: connect
Changed: 2018-03-16T19:43:39+01:00
|
